[Federal Register Volume 79, Number 110 (Monday, June 9, 2014)]
[Notices]
[Page 32961]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-13387]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices (ACIP)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announce the following meeting of the aforementioned 
committee:

    Times and Dates:

8:00 a.m.-6:00 p.m., June 25, 2014.
8:00 a.m.-1:30 p.m., June 26, 2014.

    Place: Centers for Disease Control and Prevention, Tom Harkin 
Global Communications Center, 1600 Clifton Road NE., Building 19, 
Kent ``Oz'' Nelson Auditorium, Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The committee is charged with advising the Director, 
CDC, on the appropriate use of immunizing agents. In addition, under 
42 U.S.C. Sec.  1396s, the committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines. Further, under provisions of the Affordable Care Act, 
at section 2713 of the Public Health Service Act, immunization 
recommendations of the ACIP that have been adopted by the Director 
of the Centers for Disease Control and Prevention must be covered by 
applicable health plans.
    Matters for Discussion: The agenda will include discussions on: 
Yellow fever vaccine, human papillomavirus vaccines, influenza, 
pneumococcal conjugate vaccine, tetanus, diphtheria, and acellular 
pertussis vaccine in healthcare personnel, meningococcal vaccines, 
child/adolescent immunization, adult immunization, immunization 
safety, measles, hepatitis vaccines and vaccine supply. 
Recommendation votes are scheduled for yellow fever vaccine and 
influenza. Time will be available for public comment.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Stephanie Thomas, National 
Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton 
Road NE., MS-A27, Atlanta, Georgia 30333, telephone 404/639-8836; 
Email [email protected].
    Meeting is webcast live via the World Wide Web; for instructions 
and more information on ACIP please visit the ACIP Web site: http://www.cdc.gov/vaccines/acip/index.html.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2014-13387 Filed 6-6-14; 8:45 am]
BILLING CODE 4160-18-P